Daniel Carlat Starts a Blog to Ban Commercial CME

For years, criticism of drug marketing has focused most on reps delivering dubious info and expensive DTC campaigns. But a tide seems to be turning against CME, which is mostly underwritten by drug companies. Daniel Carlat, who is already known for his Carlat Report publication, has started a blog dedicated to banning drug company funded CME. You can check it out here.